Volume 5, Issue 3 pp. 159-167
Full Access

Measuring quality of life in oncology: is it worthwhile? I. Meaning, purposes and controversies

ALI MONTAZERI BSc, MPH

Corresponding Author

ALI MONTAZERI BSc, MPH

PhD candidate

Department of Public Health, University of Glasgow, Scotland, UK

address: Ali Montazeri, 2 Lilybank Gardens, Department of Public Health, University of Glasgow, Glasgow G12 8RZ, UK.Search for more papers by this author
CHARLES R. GILLIS MD, FRCP (Glas), FFPHM

CHARLES R. GILLIS MD, FRCP (Glas), FFPHM

Director

West of Scotland Cancer Surveillance Unit, Ruchill Hospital, Glasgow, Scotland, UK

Search for more papers by this author
JAMES McEWEN FRCP(Glas), FFPHM

JAMES McEWEN FRCP(Glas), FFPHM

Professor and Head

Department of Public Health, University of Glasgow, Scotland, UK

Search for more papers by this author
First published: September 1996
Citations: 21

Abstract

This is the first of a two-part paper on quality of life in cancer patients. This part examines some of the fundamental issues in health-related quality of life measurement with particular attention being given to cancer medicine, thus helping to focus the direction and methodological rigour required in future investigations. Relevant topics are discussed to illustrate the importance of quality of life measures in cancer care. A perspective on the meaning of ‘outcome’ and ‘quality of life’ are presented to demonstrate the controversies that exist in the field. It is concluded that despite methodological limitations, quality of life measures have a potential role in advancing cancer care.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.